Prevention of late-onset cytomegalovirus infection and disease in Donor-Positive/Recipient-Negative kidney transplant recipients using low-dose valganciclovir

K Nanmoku, T Shinzato, T Kubo, T Shimizu… - Transplantation …, 2018 - Elsevier
Background The main challenge with cytomegalovirus (CMV) prophylaxis in IgG donor-
positive/recipient-negative (D+/R–) kidney transplant recipients is late-onset CMV disease …
被引用次数：7 相关文章

Prevention of late-onset cytomegalovirus infection and disease in donor-positive/recipient-negative kidney transplant recipients using low-dose valganciclovir.

K Nanmoku, T Shinzato, T Kubo, T Shimizu, T Kimura… - 2018 - cabidigitallibrary.org
Background: The main challenge with cytomegalovirus (CMV) prophylaxis in IgG donor-
positive/recipient-negative (D+/R-) kidney transplant recipients is late-onset CMV disease …

[引用][C] Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose …

K Nanmoku, T Shinzato, T Kubo, T Shimizu… - Transplantation …, 2018 - cir.nii.ac.jp
Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative
Kidney Transplant Recipients Using Low-Dose Valganciclovir | CiNii Research CiNii 国立 …

Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir

K Nanmoku, T Shinzato, T Kubo… - Transplantation …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The main challenge with cytomegalovirus (CMV) prophylaxis in IgG donor-
positive/recipient-negative (D+/R-) kidney transplant recipients is late-onset CMV disease …

Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.

K Nanmoku, T Shinzato, T Kubo, T Shimizu… - Transplantation …, 2018 - europepmc.org
Background The main challenge with cytomegalovirus (CMV) prophylaxis in IgG donor-
positive/recipient-negative (D+/R-) kidney transplant recipients is late-onset CMV disease …